Novalung announced today that it has received approval for the new NovaPort twin® double-lumen cannula, which is now available for clinical use.
The NovaPort® twin cannula was specifically designed for veno-venous vascular access for the iLA activve® system - the Allrounder for extrapulmonary lung support. The iLA activve® system can now be applied more rapidly, since cannulation with the NovaPort® twin only requires a single vein rather than the two vessels previously needed. Blood is drawn from the patient and - after passing through the iLA Membrane Ventilator® - returned to the body through the same cannula, which consists of two separate lumens.
The NovaPort® twin cannula enables the use of the jugular vein in the patient’s neck, rather than requiring femoral vessels in the groin, and thus supports the therapeutic goal of mobilizing the patient early on while treatment with the iLA activve® continues. Patient positioning and mobilisation procedures with the NovaPort® twin cannula will be familiar to nurses and physicians alike from treating hemofiltration patients. Dr. med. Georg Matheis, Managing Director of Novalung GmbH, explained: “Physicians and nurses will be able to respond to the individual patient’s therapeutic needs, regardless of whether he or she is lying in bed, sitting up or even starting to take a few steps.“
Novalung’s NovaPort® cannulas are known for their minimal flow resistance and excellent anti-kinking characteristics due to the high-flex design, while remaining extremely flexible. NovaPort® twin cannulas are introduced percutaneously using the familiar Seldinger technique. The integrated single-step dilator is especially gentle on the vessel walls. Since its inception Novalung has focussed on „Made in Germany“ to maintain the high quality of its products.
The NovaPort® twin cannula was specifically designed for veno-venous vascular access for the iLA activve® system - the Allrounder for extrapulmonary lung support. The iLA activve® system can now be applied more rapidly, since cannulation with the NovaPort® twin only requires a single vein rather than the two vessels previously needed. Blood is drawn from the patient and - after passing through the iLA Membrane Ventilator® - returned to the body through the same cannula, which consists of two separate lumens.
The NovaPort® twin cannula enables the use of the jugular vein in the patient’s neck, rather than requiring femoral vessels in the groin, and thus supports the therapeutic goal of mobilizing the patient early on while treatment with the iLA activve® continues. Patient positioning and mobilisation procedures with the NovaPort® twin cannula will be familiar to nurses and physicians alike from treating hemofiltration patients. Dr. med. Georg Matheis, Managing Director of Novalung GmbH, explained: “Physicians and nurses will be able to respond to the individual patient’s therapeutic needs, regardless of whether he or she is lying in bed, sitting up or even starting to take a few steps.“
Novalung’s NovaPort® cannulas are known for their minimal flow resistance and excellent anti-kinking characteristics due to the high-flex design, while remaining extremely flexible. NovaPort® twin cannulas are introduced percutaneously using the familiar Seldinger technique. The integrated single-step dilator is especially gentle on the vessel walls. Since its inception Novalung has focussed on „Made in Germany“ to maintain the high quality of its products.
